Contents of this document
- Pricing and number of users for AI Home Nursing Scoring
- Inclusion of the new service in the medium-term management plan
- Revenue growth by customer category and support measures
- Medium-term NRR target
- Effect of iBow adoption on visit volume
- Billable contracts and pricing structure for AI Visit Scheduling and Routing
- Consideration of price revisions
- Risk of competitors following with AI offerings
- Inquiries and switching following revisions to medical service fees
- Long-term growth strategy and investment areas
- Cash and deposits, M&A and shareholder return policy
- Investor relations activities
- Percentage of women in management and executive positions
- Development and provision of AI Home Nursing Scoring
- Increased investment in AI development
- Strengthening the customer success and sales organizations
- Recruitment and team formation for けあログっと
- Consideration of whether to revise prices, which services would be affected and the timing
- Expansion of video communications and IR fairs and briefings
- NRR108.0 %
- NRR target110 or higher
- AI Visit Scheduling and Routing services to begin billing in July246 Engagements
- Expected period-end contracts for AI Visit Scheduling and Routing400 Approximately contracts
- Annual meetings with institutional investors200 Approximately contracts
- Annual press release target40 Cases or more
- Indicative consulting fee for AI Home Nursing Scoring30,000–50,000
- Revenue per visit at a home nursing station¥8,500
- Average monthly visits500 visits/station
- Indicative nationwide monthly visits400~500
- Model visits per nurse6 Appointments/day
- Industry-standard model4 Appointments/day
- TargetRevenue of more than ¥6 billionTarget fiscal year2,028
- Target50% market shareTarget fiscal year2,040
- TargetNRR of 110% or higherTarget fiscal yearMedium term
| Item | Details |
|---|---|
| Document type | Summary of Q&A |
| Fiscal Period Covered | Second quarter of the fiscal year ending December 2026 |
| Gross Profit Margin | Trending downward. The specific margin and year-on-year change are not disclosed |
| Key KPIs | Indicator name NRR / Value 108.0 % / Year on year against the same period last year Not disclosed, Indicator name NRR target / Value 110 or higher / Year on year against the same period last year Not disclosed, Indicator name AI Visit Scheduling and Routing services to begin billing in July / Value 246 Engagements / Year on year against the same period last year Not disclosed, Indicator name Expected period-end contracts for AI Visit Scheduling and Routing / Value 400 Approximately contracts / Year on year against the same period last year Not disclosed, Indicator name Annual meetings with institutional investors / Value 200 Approximately contracts / Year on year against the same period last year Not disclosed, Indicator name Annual press release target / Value 40 Cases or more / Year on year against the same period last year Not disclosed |
| Unit price and quantity metrics | Indicator name Indicative consulting fee for AI Home Nursing Scoring / Value 30,000–50,000, Indicator name Revenue per visit at a home nursing station / Value ¥8,500, Indicator name Average monthly visits / Value 500 visits/station, Indicator name Indicative nationwide monthly visits / Value 400~500, Indicator name Model visits per nurse / Value 6 Appointments/day, Indicator name Industry-standard model / Value 4 Appointments/day |
| Number of employees | Number of Employees 118 people / Changes during the period and hiring plan Plans to recruit over the medium to long term the personnel needed for the new けあログっと care-log service |
| Medium-term management plan targets | Target Revenue of more than ¥6 billion / Target fiscal year 2,028, Target 50% market share / Target fiscal year 2,040, Target NRR of 110% or higher / Target fiscal year Medium term |
| Annual Dividend | Dividend increases have continued since listing. The specific amount is not disclosed |
| Acquisition of treasury shares | Considering flexible options based on stock market conditions, liquidity and capital efficiency. The amount, number of shares and period are not disclosed |
| Market Size / Share | Targeting a 50% market share in 2040. The current market size and share are not disclosed |
| Key points of the Q&A | Pricing and number of users for AI Home Nursing Scoring, Inclusion of the new service in the medium-term management plan, Revenue growth by customer category and support measures, Medium-term NRR target, Effect of iBow adoption on visit volume, Billable contracts and pricing structure for AI Visit Scheduling and Routing, Consideration of price revisions, Risk of competitors following with AI offerings, Inquiries and switching following revisions to medical service fees, Long-term growth strategy and investment areas, Cash and deposits, M&A and shareholder return policy, Investor relations activities, Percentage of women in management and executive positions |
| New initiatives | Development and provision of AI Home Nursing Scoring, Increased investment in AI development, Strengthening the customer success and sales organizations, Recruitment and team formation for けあログっと, Consideration of whether to revise prices, which services would be affected and the timing, Expansion of video communications and IR fairs and briefings |
Items this document does not state (19)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Revenue from the new service has not been incorporated into the medium-term management plan and is positioned as an upside factor. In terms of performance, the company explained that the gross profit margin has been trending downward because of higher personnel, outsourcing and server costs.